Pyrytyon zinc | Skin-cap aerosol external 0.2% 35 g
Special Price
$50.96
Regular Price
$59.00
In stock
SKU
BID465305
Release form
Aerosol for external use.
Aerosol for external use.
Release form
Aerosol for external use.
packaging
aerosol can 35 g.
Pharmacological action of
Pharmacotherapeutic group:
Dermatoprotective agent
ATX code [D11AX12]
Pharmacological properties:
Pharmacodynamics:
Activated zinc has anti-inflammatory and anti-inflammatory effects. Antifungal activity is especially pronounced when acting on Pityrosporum ovale and Pityrosporum orbiculare, causing inflammation and excessive peeling with dandruff, seborrhea, psoriasis and other skin diseases. The antibacterial activity of zinc pyrithione is manifested in relation to a number of pathogenic microorganisms (streptococcus, staphylococcus, Pseudomonas aeruginosa, Escherichia coli, Proteus, etc.) Zinc pyrithione reduces intracellular ATP level, contributes to the depolarization of cell membranes, causing the death of fungi and bacteria.
Pharmacokinetics:
When applied topically, activated pyrithione zinc is deposited in the epidermis and surface layers of the dermis. Systemic absorption occurs slowly. It is found in blood in trace amounts.
Indications
Psoriasis, atopic dermatitis (eczema, neurodermatitis), seborrheic dermatitis in adults and children from 1 year old.
Contraindications
Hypersensitivity to the components of the drug.
Use during pregnancy and lactation
During pregnancy and lactation, the drug should be prescribed only in cases where the expected benefits of therapy for the mother outweigh the potential risk to the fetus or infant.
No adverse effects were reported with the use of zinc pyrithione preparations by pregnant women and women during breastfeeding.
Special instructions
Before using Skin-cap, shake the bottle thoroughly several times.
Keep spray bottle upright while spraying.
For the convenience of treating the scalp, a special nozzle is included.
Composition
Composition per 100 g:
Active ingredient:
Zinc pyrithione activated 0.2 g
excipients:
isopropyl myristate 48.37 g,
polysorbate-80 0.32 g,
trolamine 0.04 g 34.0 g,
water 0.5 g
propellants up to 100 g: isobutane 76.2%, propane 23.29%, butane 0.51%.
Description:
An oily solution from white with a yellowish tinge to light yellow in color with a characteristic odor.
Dosage and administration of
A sufficient amount of the drug from a distance of about 15 cm is sprayed onto the affected skin 2-3 times a day until a clinical effect is achieved. To achieve a lasting effect, the use of the drug is recommended to continue for one week after the disappearance of symptoms. A special nozzle is attached to treat the scalp with a drug. The course of treatment for psoriasis is 1-1.5 months, with atopic dermatitis 3-4 weeks.
Method of administration and doses in pediatrics: method of administration and doses in children do not differ from the method of administration and doses in adults.
If necessary, a second course of treatment can be carried out 1-1.5 months after consulting a doctor.
Side effects
Rarely - allergic reaction.
In the first days of treatment, there may be a short-term burning sensation at the site of application of the drug, which, as a rule, does not require discontinuation of the drug.
Storage conditions
At a temperature of 4 to 30 C.
Out of the reach of children.
Expiration
5 years.
Deystvuyuschee substances
Pyrytyon zinc
over-the-counter pharmacy conditions
over-the-counter
Form of Treatment
spray for outdoor use
Resifarm Parets SL, Spain
Aerosol for external use.
packaging
aerosol can 35 g.
Pharmacological action of
Pharmacotherapeutic group:
Dermatoprotective agent
ATX code [D11AX12]
Pharmacological properties:
Pharmacodynamics:
Activated zinc has anti-inflammatory and anti-inflammatory effects. Antifungal activity is especially pronounced when acting on Pityrosporum ovale and Pityrosporum orbiculare, causing inflammation and excessive peeling with dandruff, seborrhea, psoriasis and other skin diseases. The antibacterial activity of zinc pyrithione is manifested in relation to a number of pathogenic microorganisms (streptococcus, staphylococcus, Pseudomonas aeruginosa, Escherichia coli, Proteus, etc.) Zinc pyrithione reduces intracellular ATP level, contributes to the depolarization of cell membranes, causing the death of fungi and bacteria.
Pharmacokinetics:
When applied topically, activated pyrithione zinc is deposited in the epidermis and surface layers of the dermis. Systemic absorption occurs slowly. It is found in blood in trace amounts.
Indications
Psoriasis, atopic dermatitis (eczema, neurodermatitis), seborrheic dermatitis in adults and children from 1 year old.
Contraindications
Hypersensitivity to the components of the drug.
Use during pregnancy and lactation
During pregnancy and lactation, the drug should be prescribed only in cases where the expected benefits of therapy for the mother outweigh the potential risk to the fetus or infant.
No adverse effects were reported with the use of zinc pyrithione preparations by pregnant women and women during breastfeeding.
Special instructions
Before using Skin-cap, shake the bottle thoroughly several times.
Keep spray bottle upright while spraying.
For the convenience of treating the scalp, a special nozzle is included.
Composition
Composition per 100 g:
Active ingredient:
Zinc pyrithione activated 0.2 g
excipients:
isopropyl myristate 48.37 g,
polysorbate-80 0.32 g,
trolamine 0.04 g 34.0 g,
water 0.5 g
propellants up to 100 g: isobutane 76.2%, propane 23.29%, butane 0.51%.
Description:
An oily solution from white with a yellowish tinge to light yellow in color with a characteristic odor.
Dosage and administration of
A sufficient amount of the drug from a distance of about 15 cm is sprayed onto the affected skin 2-3 times a day until a clinical effect is achieved. To achieve a lasting effect, the use of the drug is recommended to continue for one week after the disappearance of symptoms. A special nozzle is attached to treat the scalp with a drug. The course of treatment for psoriasis is 1-1.5 months, with atopic dermatitis 3-4 weeks.
Method of administration and doses in pediatrics: method of administration and doses in children do not differ from the method of administration and doses in adults.
If necessary, a second course of treatment can be carried out 1-1.5 months after consulting a doctor.
Side effects
Rarely - allergic reaction.
In the first days of treatment, there may be a short-term burning sensation at the site of application of the drug, which, as a rule, does not require discontinuation of the drug.
Storage conditions
At a temperature of 4 to 30 C.
Out of the reach of children.
Expiration
5 years.
Deystvuyuschee substances
Pyrytyon zinc
over-the-counter pharmacy conditions
over-the-counter
Form of Treatment
spray for outdoor use
Resifarm Parets SL, Spain
Write Your Own Review